Here is some other vaccine news of note for the week:
> The National Institutes of Health started a first-in-human study of a NIAID-developed live attenuated Zika virus vaccine candidate. Release
> VBI Vaccines appointed Christopher McNulty as its chief financial officer and head of business development. Release
> The Securities and Exchange Commission decided against further action after an investigation into possible securities law violations at Sinovac. Release
> BiondVax has moved manufacturing for its universal flu vaccine candidate to a new facility in the Jerusalem Bio Park. Release